Article Name Medical Devices
Non-Invasive TMS Device Aims to Enhance Mental Health by Targeting Neural Activity with Magnetic Pulses
11th April, 2025
Innovative Design Offers Precise Ventilation and Intuitive Operation for Diverse Surgical Settings
10th April, 2025
Health Canada Approval Enables Canadian Clinicians to Enhance Cardiac and Pulmonary Care with Advanced AI-Powered Tools
10th April, 2025
Innovative Technology Enables Safe Access to Pericardial Space Without Exposed Needles, Enhancing Cardiac Interventions
16th April, 2025
New Category III Codes Facilitate Integration of CaRi-Heart® into Clinical Practice for Enhanced Cardiac Risk Assessment
09th April, 2025
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatments
09th April, 2025
New Infusion Devices Enhance Accuracy and Expand ICU Medical's IV Performance Platform
08th April, 2025
Advanced Machine Learning Tool Integrates with Shoulder Planning App to Personalize Surgical Predictions
08th April, 2025
Research Presented at Radiosurgery Society Meeting Showcases Precision and Clinical Advantages
04th April, 2025
Advanced Features Enhance Diagnostic Precision and Workflow Efficiency
04th April, 2025
Advanced Diagnostic Technology Aims to Enhance Detection of Connective Tissue Diseases
04th April, 2025
Digital Therapeutic Enhances Mobility and Quality of Life for PD Patients
03rd April, 2025
Funding to Support Innovation and Global Expansion in Robotic Surgery
03rd April, 2025
• One-third of all deaths in Singapore are caused by cardiovascular disease (CVD), with stroke, and myocardial infarction (MI) being the leading causes of death, driving the need for percutaneous coronary intervention (PCI) • Building upon the results of the BIOADAPTOR RCT (randomized clinical trial), the 12- month data from the INFINITY-SWEDEHEART trial further validates the DynamX® Coronary Bioadaptor System’s unique mechanism of action in complex PCI population subsets • The 12 months’ primary outcomes of the INFINITY-SWEDEHEART trial were published in The Lancet
03rd April, 2025
Collaboration Aims to Advance Cutting-Edge Solutions for Improved Patient Care
02nd April, 2025
Advanced Telehealth Solutions Aim to Reduce Hospital Readmissions and Improve Patient Care
02nd April, 2025
Milestone Marks Completion of First-in-Human Study for Innovative OA Therapy
02nd April, 2025
Collaboration Advances Personalized Orthopedic Care with Cutting-Edge 3D Technology
02nd April, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer